Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used to treat type 2 diabetes and obesity, seems to reduce ...

Exercise decreased the risk of atherosclerosis development in patients with obesity on a weight-loss maintenance program, a benefit not seen with a GLP-1 agonist during the randomized trial, a ...

In adults with obesity who achieve ≥ 5% weight loss on a low-calorie diet, a 1-year exercise program produces a greater increase in late-phase postprandial GLP-1 response compared with usual activity, ...

A new Tel Aviv University study shows that resistance training, including exercises like squats and pushups, is key to ...

A new study published in the academic journal PLOS ONE suggests that yoga is a viable way to improve the physical and cognitive faculties necessary for maintaining long-term weight loss, even if it ...

An independent informational overview of MEDVi's compounded tirzepatide telehealth program, including regulatory ...

An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...

It is often difficult to keep a regular exercise program. If working out is internally satisfying, you are likely to stick ...

A very-low-calorie diet and weight loss combined with exercise does not appear to offer any greater reductions in hip osteoarthritis (OA) pain compared to exercise alone, even in people who are ...

Costly GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and Zepbound could be covered under the new plan A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the ...

People with serious mental illness have higher rates of overweight and obesity, and obesity-related illnesses can worsen psychiatric symptoms. A 6-month fully remote weight-loss program tailored to ...